keyword
posttranspl
infect
posttranspl
icu
care
solid
organ
transplant
risk
factor
solid
organ
transplant
sot
becom
wellestablish
standard
care
endorgan
failur
nurs
intens
care
unit
may
expos
patient
stage
care
continuum
pretranspl
posttranspl
care
factor
affect
incid
infect
sot
includ
type
organ
transplant
anatom
region
transplant
incid
surgic
complic
level
immunosuppress
antireject
therapi
knowledg
risk
factor
time
treatment
infect
may
help
enhanc
clinic
practic
optim
patient
safeti
clinic
outcom
crit
care
nur
clin
n
http
dx
year
unit
state
organ
transplant
offer
lifelin
individu
endstag
organ
dysfunct
unit
network
organ
share
keep
talli
number
transplant
donor
patient
wait
solid
organ
transplant
sot
april
wait
list
candid
donor
accord
unit
network
organ
share
websit
solid
organ
demand
kidney
patient
wait
list
close
follow
almost
peopl
wait
liver
approxim
candid
wait
heart
transplant
littl
candid
wait
lung
pancrea
transplant
number
donor
kidney
liver
transplant
increas
past
year
possibl
owe
increas
live
donor
transplant
fiveyear
surviv
rate
kidney
transplant
recipi
roughli
liver
transplant
recipi
around
transplant
recipi
risk
complic
relat
surgic
procedur
immunosuppress
therapi
infect
infect
remain
common
complic
sot
articl
discuss
infect
sot
recipi
includ
kidney
heart
lung
pancrea
transplant
earli
postop
infect
import
sourc
morbid
mortal
sot
recipi
factor
affect
incid
infect
sot
includ
type
organ
transplant
anatom
region
transplant
incid
surgic
complic
level
immunosuppress
antireject
therapi
limit
highlevel
evid
exist
epidemiolog
risk
factor
earli
nosocomi
infect
sot
recipi
howev
third
edit
american
societi
transplant
guidelin
prevent
treatment
infecti
complic
solid
organ
transplant
offer
guid
clinic
practic
provid
evid
exist
clinic
consensu
critic
apprais
evid
limit
mani
classic
clinic
marker
inflammatori
sign
symptom
associ
infect
diminish
sot
recipi
owe
immunosuppress
therefor
usual
indic
fever
leukocytosi
wound
erythema
alway
appreci
addit
usual
pain
pathway
may
disrupt
owe
alter
anatomi
organ
denerv
affect
recognit
infect
subsequ
delay
diagnosi
increas
risk
morbid
mortal
transplant
recipi
particularli
suscept
infect
episod
increas
immunosuppress
observ
close
sign
infect
tradit
test
method
seek
infecti
sourc
may
limit
diagnosi
acut
diseas
transplant
bacteri
fungal
cultur
often
lower
yield
radiograph
often
insuffici
diagnos
infect
thorough
pretranspl
screen
perform
identifi
infecti
diseas
may
preclud
donor
recipi
transplant
includ
detail
medic
histori
prior
infect
past
travel
place
resid
exposur
anim
environment
pathogen
standard
screen
includ
human
immunodefici
viru
hiv
cytomegaloviru
cmv
immunoglobulin
ig
g
antibodi
hepat
b
viru
hbv
hepat
c
viru
hcv
rapid
plasma
reagin
toxoplasma
antibodi
epsteinbarr
viru
antibodi
varicellazost
viru
antibodi
addit
test
base
patient
histori
chest
radiographi
microbiolog
test
blood
urin
commonli
includ
screen
process
donor
screen
process
influenc
time
sensit
natur
organ
transplant
abil
conduct
rapid
cycl
test
organ
transplant
risk
factor
separ
pretranspl
intraop
posttranspl
pretranspl
risk
factor
divid
donor
recipi
rigor
select
process
team
highli
train
specialist
need
screen
candid
transplant
patient
risk
factor
assess
includ
pretranspl
infect
especi
multidrug
resist
mdr
organ
sever
ill
function
capac
psychosoci
assess
abil
selfcar
posttranspl
donorderiv
infect
occur
approxim
deceas
donor
transplant
may
mitig
care
medic
social
histori
physic
assess
organ
screen
infect
transmiss
bacteria
mdr
bacteria
methicillinresist
staphylococcu
aureu
mrsa
vancomycinresist
enterococcu
vre
result
graft
loss
increas
morbid
mortal
donor
bacteremia
may
use
howev
recommend
donor
receiv
target
antimicrobi
therapi
least
day
transplant
demonstr
clinic
improv
recipi
receiv
organ
infect
donor
receiv
cours
antibiot
target
organ
isol
donor
donorderiv
infect
result
organ
transplant
activ
latent
infect
may
may
expect
exampl
infect
expect
transmiss
includ
cmv
hbv
wherea
pathogen
may
unexpect
includ
hiv
chaga
hcv
lymphocyt
choriomening
viru
mycobacterium
tuberculosi
mdr
rabi
west
nile
viru
addit
group
infect
west
nile
viru
hiv
rabi
lymphocyt
choriomening
viral
infect
chaga
diseas
associ
deceas
donor
pathogen
may
detect
pretranspl
screen
owe
delay
seroconvers
sensit
test
therefor
transplant
organ
deceas
donor
fever
viral
syndrom
may
controversi
colon
bacteri
fungal
infect
donor
present
infecti
concern
transplant
organ
recipi
henc
earli
recognit
along
prophylaxi
treatment
subclin
infect
recommend
unit
state
organ
procur
transplant
network
monitor
diseas
transmiss
nation
registri
multipl
factor
impact
transplant
recipi
risk
infect
oper
period
type
surgic
reconstruct
unexpect
surgic
event
ischem
injuri
prolong
oper
time
oper
field
contamin
excess
bleed
organ
injuri
exampl
surgic
risk
includ
select
biliari
anastomosi
liver
transplant
patient
lead
postop
biliari
complic
deceas
donor
dysfunct
kidney
allograft
lead
higher
rate
urinari
tract
infect
uti
posttranspl
immunosuppress
prevent
reject
signific
risk
factor
opportunist
infect
microbiolog
surveil
assay
measur
immun
assess
infecti
risk
place
common
posttranspl
pathogen
mdr
bacteria
virus
fungi
close
attent
transplant
organ
essenti
detect
complic
vascular
suppli
organ
function
could
lead
increas
risk
infect
expediti
remov
devic
prevent
catheterrel
infect
highli
recommend
gener
prevent
strategi
includ
vaccin
univers
prophylaxi
preemptiv
therapi
ideal
vaccin
provid
transplant
immunosuppress
critic
ill
may
decreas
vaccin
effect
best
time
vaccin
panel
includ
live
vaccin
attenu
vaccin
earli
cours
diseas
transplant
smallpox
oral
polio
calmetteguerin
bacillu
live
attenu
vaccin
contraind
transplant
lifestyl
chang
import
transplant
includ
measur
decreas
risk
infect
hand
wash
food
prepar
garden
contact
fece
secret
attent
food
prepar
includ
undercook
meat
unwash
fruit
veget
unpasteur
dairi
product
avoid
well
water
import
transplant
recipi
prevent
infect
time
infect
sot
fairli
predict
irrespect
organ
type
common
time
frame
relat
sot
categor
earli
intermedi
late
tabl
earli
time
period
within
first
month
transplant
usual
associ
bacteri
candid
infect
intermedi
phase
relat
month
infect
commonli
link
transplant
late
period
month
compris
infect
usual
relat
chronic
reject
advanc
power
immunosuppress
agent
decreas
incid
reject
transplant
organ
increas
patient
suscept
opportunist
infect
cancer
routin
antimicrobi
prophylaxi
pneumocysti
jirovecii
cmv
chang
pattern
posttranspl
opportunist
infect
influenc
emerg
new
clinic
syndrom
polyomaviru
type
bk
nephropathi
organ
antimicrobi
resist
infect
immunosuppress
sot
recipi
often
difficult
distinguish
sign
symptom
infect
often
diminish
noninfecti
caus
fever
allograft
reject
toxic
drug
interact
may
exist
case
laboratori
test
includ
quantit
assay
sometim
assist
detect
specif
infect
hbv
exampl
infect
transmit
transplant
risk
mitig
test
transplant
candid
hbv
hepat
b
surfac
antigen
antihepat
b
surfac
antihepat
b
core
vaccin
antivir
prophylaxi
infect
earli
posttranspl
period
larg
donor
deriv
recipi
derivedcolon
nosocomi
pathogen
relat
complic
surgeri
bacteria
yeast
least
bacteri
infect
transplant
aris
earli
period
mani
label
surgic
site
infect
ssi
deriv
anastomot
stenosi
leak
surgic
complic
fluid
collect
devit
tissu
graft
injuri
anastomot
issu
risk
factor
develop
seriou
invas
infect
donorderiv
bacteri
fungal
infect
transfer
allograft
report
organ
procur
agenc
mitig
risk
organ
recipi
assess
antimicrobi
suscept
prophylaxi
need
specimen
biopsi
concern
period
warrant
investig
includ
clostridium
difficil
coliti
hepat
pneumon
enceph
rash
leukopenia
infect
commonli
seen
intermedi
period
opportunist
pathogen
immunocompromis
host
infect
often
link
transplant
latent
pathogen
transmit
donor
organ
reactiv
within
recipi
transfer
blood
product
potenti
pathogen
includ
polyomaviru
bk
adenoviru
recurr
hcv
herpesviru
infect
varicella
zoster
cmv
epsteinbarr
viru
lymphoprolif
disord
posttranspl
lymphoprolif
disord
p
jirovecii
pneumonia
toxoplasmosi
aspergillu
tuberculosi
cryptococcu
trypanosoma
cruzi
strongyloid
may
occur
absenc
appropri
prophylaxi
prevent
measur
antibacteri
prophylaxi
trimethoprimsulfamethoxazol
usual
administ
uti
opportunist
infect
pneumocysti
pneumonia
listeria
monocytogen
infect
toxoplasma
gondii
infect
infect
sulfasuscept
nocardia
spp
risk
infect
usual
decreas
late
posttranspl
period
immunosuppress
therapi
usual
taper
allograft
function
optim
individu
comorbid
condit
diabet
mellitu
underli
diseas
malign
continu
increas
risk
infect
later
phase
individu
requir
increas
immunosuppress
either
relat
reject
underli
diseas
greater
risk
late
opportunist
infect
allograft
injuri
persist
owe
chronic
viral
infect
cirrhosi
hcv
liver
transplant
recipi
stenotrophomona
pseudomona
aspergillu
bronchiol
obliteran
lung
transplant
recipi
acceler
vasculopathi
hearttranspl
recipi
cmv
malign
disord
posttransplant
lymphoprolif
disord
immunosuppress
transplant
patient
continu
increas
risk
opportunist
infect
listeria
nocardia
spp
invas
fungal
pathogen
zygomycet
dematiac
mold
unusu
organ
eg
rhodococcu
spp
pneumonia
commonli
diagnos
nosocomi
infect
surgic
patient
often
seen
earli
phase
sot
hospitalacquir
pneumonia
hospitalacquir
infect
occur
hour
hospit
stay
increas
risk
patient
requir
mechan
ventil
via
endotrach
intub
diagnosi
uti
adult
requir
presenc
dysuria
increas
urinari
frequenc
suprapub
tender
combin
posit
urin
cultur
common
caus
pathogen
gramneg
bacteria
includ
escherichia
coli
e
cloaca
acinetobact
baumannii
high
percentag
sot
patient
found
colon
mrsa
vre
lead
increas
risk
ensu
infect
ssi
defin
postop
infect
around
surgic
incis
superfici
deep
organ
involv
occur
within
day
devic
implant
diagnosi
ssi
requir
posit
cultur
surgic
site
purul
exud
surgic
wound
surgic
incis
requir
reopen
ssi
gener
surgic
popul
consid
prevent
increas
risk
among
advanc
age
diabet
smoke
histori
obes
lengthi
oper
time
ssi
link
longer
durat
stay
intens
care
unit
icu
frequent
hospit
readmiss
increas
morbid
mortal
cost
excess
per
infect
patient
blood
stream
infect
bsi
gener
surgic
popul
transplant
recipi
associ
signific
morbid
mortal
increas
risk
red
blood
cell
transfus
parenter
nutrit
age
immunosuppress
medic
comorbid
includ
diabet
peripher
vascular
diseas
congest
heart
failur
renal
liver
diseas
incid
bsi
within
day
sot
rang
approxim
incid
organ
transplant
kidney
pancreaskidney
liver
transplant
gramposit
bacteria
frequent
isol
transplant
recipi
although
gramneg
frequent
among
kidney
liver
transplant
recipi
antibiot
resist
common
mdr
hospitalacquir
infect
becom
signific
risk
transplant
uti
common
infect
kidney
transplant
like
owe
anatom
disrupt
urinari
tract
surgeri
presenc
ureter
cathet
first
week
posttranspl
preexist
urinari
tract
abnorm
risk
factor
bsi
kidney
transplant
recipi
includ
abo
incompat
previou
cmv
infect
pretranspl
dialysi
acut
reject
urolog
diseas
presenc
ureter
stent
high
posttranspl
serum
creatinin
level
gramneg
bacteria
identifi
main
pathogen
respons
bsi
group
e
coli
pseudomona
aeruginosa
klebsiella
spp
enterobact
spp
baumanii
gramposit
bacteria
identifi
main
pathogen
respons
bsi
group
coagulaseneg
staphylococci
enterococcu
spp
aureu
incid
candidemia
renal
transplant
low
common
spp
identifi
c
albican
c
parapsilosi
c
glabrata
kidney
transplant
recipi
signific
risk
develop
infect
mdr
pathogen
vre
mrsa
extendedspectrum
betalactamaseproduc
klebsiella
pneumonia
carbapenemresist
baumannii
carbapenemresist
p
aeruginosa
extendedspectrum
betalactamaseproduc
enterobact
spp
incid
earli
nosocomi
pneumonia
kidney
transplant
recipi
rang
around
common
bacteri
pathogen
includ
aureu
p
aeruginosa
acinetobact
spp
haemophilu
influenza
nosocomi
pneumonia
kidney
transplant
recipi
mortal
common
infect
kidney
transplant
recipi
uti
estim
subsequ
bacteremia
patient
risk
factor
nosocomi
uti
includ
age
femal
gender
durat
bladder
catheter
use
ureter
stent
delay
graft
function
immunosuppress
regimen
glomerulonephr
simultan
doubl
renal
transplant
renal
transplant
recipi
uti
like
experi
fail
transplant
allograft
recipi
develop
uti
therefor
prevent
infect
control
strategi
essenti
earli
postop
uti
thought
larg
prevent
earli
cathet
remov
implement
infect
evidencebas
infect
control
practic
commonli
seen
uti
includ
e
coli
k
pneumonia
enterococcu
spp
uti
treatment
includ
trimethoprimsulfamethoxazol
prophylaxi
earli
urinari
cathet
remov
reduc
risk
uti
incid
ssi
kidney
transplant
patient
rang
gramposit
bacteria
staphylococci
enterococci
frequent
isol
organ
risk
factor
ssi
kidney
transplant
recipi
includ
pretranspl
diabet
mellitu
delay
graft
function
high
bodi
mass
index
pretranspl
glomerulonephr
acut
graft
reject
need
reoper
earli
posttranspl
implic
independ
risk
factor
develop
blood
stream
infect
kidney
transplant
bsi
complic
earli
postop
cours
renal
transplant
recipi
case
secondari
uti
catheterrel
pneumonia
gastrointestin
ssi
risk
factor
earli
bsi
kidney
transplant
recipi
includ
acut
reject
hemodialysi
transplant
local
infect
ureter
stent
transplant
deceas
donor
organ
recipi
increas
risk
mortal
kidney
transplant
recipi
develop
bsi
seen
high
acut
physiolog
chronic
health
evalu
apach
ii
score
presenc
shock
diagnosi
respiratori
failur
liver
transplant
recipi
bsi
frequent
complic
liver
transplant
recipi
part
owe
risk
rel
immunosuppress
cirrhot
patient
transplant
prolong
surgic
procedur
transplant
risk
factor
bsi
liver
transplant
includ
diabet
mellitu
hypoproteinemia
catheter
preoper
massiv
effus
ascit
preoper
aureu
carriag
posttranspl
hemodialysi
oper
blood
loss
reoper
need
mechan
ventil
bile
duct
complic
common
organ
found
liver
transplant
patient
includ
gramneg
bacilli
e
coli
gramposit
bacteria
aureu
candida
studi
show
liver
transplant
recipi
develop
least
fungal
infect
transplant
studi
show
increas
incid
infect
mdr
gramneg
organ
stenotrophomona
maltophilia
ochrobactrum
anthropi
pseudomona
spp
baumanii
addit
pretranspl
colon
vre
mrsa
result
significantli
higher
risk
infect
infect
signific
impact
mortal
rate
high
pneumonia
occur
liver
transplant
recipi
enterobacteriacea
h
influenza
p
aeruginosa
aspergillu
found
common
caus
pathogen
risk
factor
pneumonia
liver
transplant
recipi
includ
retransplant
surgic
techniqu
dialysi
increas
intern
normal
ratio
liver
transplant
restrict
lung
physiolog
prolong
mechan
ventil
nosocomi
pneumonia
liver
transplant
patient
link
mortal
high
seven
percent
liver
transplant
recipi
experi
symptomat
uti
first
month
transplant
owe
gramneg
bacteria
includ
e
coli
e
posttranspl
infect
icu
cloaca
baumannii
mani
organ
mdr
organ
result
suboptim
patient
outcom
increas
health
care
cost
tabl
liver
transplant
complex
procedur
one
highest
rate
ssi
independ
risk
factor
ssi
patient
undergo
liver
resect
includ
preoper
open
wound
surgic
techniqu
hypernatremia
hypoalbuminemia
increas
serum
bilirubin
dialysi
longer
oper
time
pathogen
caus
ssi
adult
liver
transplant
recipi
includ
enterococcu
spp
staphylococcu
spp
candida
spp
gramneg
bacteria
ssi
may
identifi
indur
erythema
tender
drainag
incis
site
risk
factor
ssi
liver
transplant
recipi
includ
increas
oper
time
hour
surgeri
last
hour
antibiot
therapi
within
month
liver
transplant
leak
biliari
anastomosi
femal
gender
hla
mismatch
increas
preoper
white
blood
cell
count
donor
liver
masstorecipi
bodi
mass
ratio
less
incid
bsi
liver
transplant
recipi
rang
bacteremia
occur
within
first
month
transplant
frequent
isol
pathogen
includ
aureu
coagulaseneg
staphylococci
extendedspectrum
betalactamaseproduc
e
coli
mdr
p
aeruginosa
candidemia
invas
fungal
infect
primari
infecti
sourc
intravascular
cathet
surgic
wound
risk
factor
bsi
includ
diabet
mellitu
serum
albumin
level
greater
mgdl
retransplant
high
transfus
requir
u
cellular
blood
product
choledochojejunostomi
posttranspl
dialysi
colon
candida
spp
transplant
pretranspl
use
fluoroquinolon
prophylaxi
spontan
bacteri
periton
inhospit
mortal
invas
candidiasi
may
high
antifung
prophylaxi
recommend
recipi
risk
factor
candidemia
incid
bsi
lung
transplant
recipi
approxim
vari
earli
late
posttranspl
time
period
cystic
fibrosi
cf
noncf
patient
common
infect
includ
aureu
p
aeruginosa
candida
spp
vascular
cathet
pulmonari
sourc
gramneg
bsi
often
owe
mdr
pathogen
includ
p
aeruginosa
burkholderia
cepacia
group
k
pneumonia
isol
wherea
pulmonari
infect
owe
resist
gramneg
pathogen
colon
bacteremia
b
cepacia
group
recogn
import
mortal
risk
factor
cf
lung
transplant
recipi
result
progress
necrot
pneumonia
persist
bacteremia
highli
resist
preval
pneumonia
lung
transplant
recipi
may
high
highest
risk
infect
occur
first
month
posttranspl
highest
mortal
cf
patient
risk
factor
includ
bilater
lung
transplant
lung
volum
reduct
redo
transplant
preoper
colon
gramneg
rod
frequent
isol
organ
lung
transplant
includ
p
aeruginosa
aureu
aspergillu
spp
cf
patient
colon
p
outbreak
period
high
preval
surveil
screen
may
necessari
aeruginosa
time
transplant
paranas
sinus
serv
reservoir
bacteria
sinu
surgeri
daili
nasal
irrig
salin
found
reduc
recolon
allograft
improv
surviv
reduc
incid
posttranspl
bronchiol
obliteran
syndrom
aspergillu
remain
common
fungal
infect
transplant
recipi
late
postop
period
may
seen
patient
admit
icu
respiratori
failur
studi
ssi
lung
transplant
recipi
howev
incid
thought
approxim
occur
empyema
surgic
wound
infect
mediastin
sternal
osteomyel
pericard
incid
pneumonia
heart
transplant
recipi
reach
high
commonli
isol
pathogen
includ
aureu
p
aeruginosa
baumanii
enterobact
cloaca
nosocomi
pneumonia
often
earli
infect
heart
transplant
associ
increas
mortal
especi
patient
requir
mechan
ventil
surgic
site
infect
heart
transplant
incid
ssi
heart
transplant
high
higher
cardiac
surgeri
link
increas
morbid
mortal
ssi
subtyp
superfici
deep
caus
gramposit
bacteria
mrsa
fungal
spp
candida
risk
factor
ssi
heart
transplant
includ
bodi
mass
index
greater
kgm
previou
heart
surgeri
prolong
cardiopulmonari
bypass
time
previou
ventricular
assist
devic
implant
inotrop
support
increas
age
immunosuppress
regimen
includ
sirolimustacrolimu
heart
transplant
recipi
develop
deep
sternal
wound
infect
mediastin
wound
dehisc
increas
inhospit
mortal
compar
patient
without
infect
similar
surviv
initi
infect
incid
bsi
heart
transplant
recipi
infect
nosocomi
central
venou
cathet
surgic
wound
lower
respiratori
tract
infect
uti
common
sourc
bacteremia
common
organ
seen
posttranspl
includ
gramneg
pathogen
includ
e
coli
p
aeruginosa
k
pneumonia
serratia
marcescen
gramposit
microorgan
includ
aureu
mrsa
staphylococcu
epidermidi
enterococcu
faecali
risk
factor
bsi
includ
hemodialysi
prolong
icu
durat
stay
previou
cmv
infect
preexist
ventricular
assist
devic
time
transplant
pancrea
kidneypancrea
transplant
recipi
risk
bacteri
infect
surgic
complic
includ
intraabdomin
infect
duoden
leak
recurr
uti
wound
infect
pulmonari
cathet
relat
sourc
common
infect
includ
enterobacteriacia
vre
acinetobact
spp
summari
sot
becom
wellestablish
standard
care
endorgan
failur
icu
nurs
may
expos
patient
stage
care
continuum
pretranspl
posttranspl
care
knowledg
risk
factor
time
treatment
infect
may
help
enhanc
clinic
practic
optim
patient
safeti
clinic
outcom
